LCTX
Lineage Cell Therapeutics Inc
0.9557$
+0.9%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.0% | 43.7% | 15.9% | 9.4% | 21.3% | 27.9% | 49.8% | 36.6% | 5.0% | 7.5% | 3.5% | 5.8% | |
| 57.0% | 56.3% | 84.1% | 90.6% | 78.7% | 72.1% | 50.2% | 63.4% | 95.0% | 92.5% | 96.5% | 94.2% | |
| 1,928.3% | 1,681.3% | 1,603.3% | 1,340.6% | 1,479.9% | 1,214.3% | 1,593.4% | 870.5% | 95.1% | 175.6% | 131.3% | 121.8% | |
| 902.0% | 1,149.7% | 1,262.3% | 1,111.7% | 1,746.2% | 1,625.9% | 2,014.4% | 467.5% | 153.1% | 193.4% | 191.3% | 126.8% | |
| 2,660.9% | 2,653.4% | 2,702.5% | 2,359.4% | 2,973.8% | 2,702.4% | 3,471.5% | 1,326.5% | 248.2% | 369.0% | 322.6% | 243.8% | |
| -2,604.0% | -2,597.0% | -2,618.4% | -2,170.9% | -2,951.6% | -2,630.3% | -3,421.3% | -1,263.1% | -153.2% | -276.5% | -226.1% | -149.6% | |
| 4.7% | 13.4% | 33.2% | 38.6% | 767.8% | 114.0% | 667.9% | 0.1% | 35.2% | – | – | – | |
| -2,628.2% | -2,472.4% | 826.9% | -1,299.6% | -3,328.4% | -1,301.4% | -2,836.2% | -1,110.6% | -175.6% | -260.3% | -195.6% | -471.6% | |
| -378.9% | -178.2% | -7,813.0% | -2,080.9% | -24.4% | -501.2% | -160.3% | -120.8% | 3.7% | -20.2% | 0.3% | -35.1% | |
| -1,870.7% | -1,854.4% | 1,490.8% | -1,114.7% | -3,247.9% | -792.2% | -2,671.3% | -1,104.2% | -178.7% | -240.2% | -195.9% | -436.5% | |
| -2,171.8% | -2,347.1% | -2,407.2% | -2,084.8% | -2,664.0% | -2,427.3% | -3,157.6% | -1,088.2% | -170.6% | -252.5% | -189.2% | -466.8% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.